Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jun 25;26(13):6090.
doi: 10.3390/ijms26136090.

New Anticancer Agents: Design, Synthesis and Evaluation

Vadim Pokrovsky  1 , Raffaele Addeo  2 , Mauro Coluccia  3
Affiliations
Editorial

New Anticancer Agents: Design, Synthesis and Evaluation

Vadim Pokrovsky et al. Int J Mol Sci. .

Abstract

Among the fundamental pathological processes, tumorigenesis is arguably the most complex [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. DeVita V.T., Lawrence T.S., Rosenberg S.A. Cancer: Principles & Practice of Oncology. 6th ed. Lippincott Williams & Wilkins; Philadelphia, PA, USA: 2001. pp. 265–272.
    1. National Cancer Institute: A to Z List of Cancer Drugs. [(accessed on 10 June 2025)]; Available online: https://www.cancer.gov/about-cancer/treatment/drugs.
    1. Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12:31–46. doi: 10.1158/2159-8290.CD-21-1059. - DOI - PubMed
    1. Galassi C., Chan T.A., Vitale I., Galluzzi L. The hallmarks of cancer immune evasion. Cancer Cell. 2024;42:1825–1863. doi: 10.1016/j.ccell.2024.09.010. - DOI - PubMed
    1. Gil-Edo R., Espejo S., Falomir E., Carda M. Synthesis and Biological Evaluation of Potential Oncoimmunomodulator Agents. Int. J. Mol. Sci. 2023;24:2614. doi: 10.3390/ijms24032614. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources